Watch TNONW. Know when insiders buy.
One email the day a filing lands. Free.
TNONW
Tenon Medical, Inc.
No price history available
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
96
PASS · shorts 96
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP —P/E —DIV YIELD —FCF YIELD —REV TTM $5.3M +80.3%NET INCOME −$13.7MNET CASH —52W —SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $1.3M | +126.8% | 63.6% | −$3.4M | −$4M | — | -12.35 | −$2.8M | $172K | −$2.9M | Aug 13 |
| Q1 2026 · Mar 31 | $1.4M | +89.9% | 68.5% | −$3.3M | −$3.5M | — | 0.31 | −$3M | $56K | −$3M | May 15 |
| Q4 2025 · Dec 31derived | $1.5M | +92.3% | 68.7% | −$2.9M | −$2.8M | — | -0.22 | −$2.2M | $192K | −$2.4M | Mar 27 |
| Q3 2025 · Sep 30 | $1.2M | +32.2% | 65.9% | −$3.4M | −$3.3M | — | -0.40 | −$3.8M | −$111K | −$3.7M | Nov 13 |
| Q2 2025 · Jun 30 | $564K | −37.4% | 43.4% | −$2.9M | −$2.8M | — | -12.76 | −$2.2M | — | — | Aug 13 |
| Q1 2025 · Mar 31 | $726K | +1.0% | 44.5% | −$3.7M | −$3.6M | — | 1.01 | −$2.5M | — | — | May 15 |
| Q4 2024 · Dec 31derived | $770K | −4.7% | 45.8% | −$3.2M | −$3.1M | — | 7.34 | −$2.8M | −$37K | −$2.7M | Mar 27 |
| Q3 2024 · Sep 30 | $887K | −6.0% | 47.1% | −$3.2M | −$3.2M | — | -3.63 | −$2.3M | $104K | −$2.4M | Nov 13 |
| Q2 2024 · Jun 30 | $901K | — | 52.2% | −$3.9M | −$3.8M | — | -8.16 | −$2.4M | $0 | −$2.4M | Aug 13 |
| Q1 2024 · Mar 31 | $719K | — | 65.4% | −$3.5M | −$3.6M | — | -10.02 | −$2.3M | $119K | −$2.5M | May 13 |
| Q4 2023 · Dec 31derived | $808K | — | 69.2% | −$3.1M | −$3.1M | — | -5.46 | −$2.3M | $92K | −$2.4M | Mar 26 |
| Q3 2023 · Sep 30 | $944K | — | 56.7% | −$3.4M | −$3.3M | — | -11.69 | −$3.2M | $57K | −$3.2M | Nov 14 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $3.9M | 59.8% | −$12.8M | −$12.6M | -318.4% | -1.70 | −$10.7M | $273K | −$11M | — | — |
| FY2024 · to Dec 31 | $3.3M | 52.2% | −$13.8M | −$13.7M | -417.2% | -11.26 | −$9.9M | $186K | −$10.1M | — | — |
| FY2023 · to Dec 31 | $2.9M | 42.4% | −$15.7M | −$15.6M | -532.1% | -68.64 | −$12.2M | $361K | −$12.5M | — | — |
| FY2022 · to Dec 31 | $691K | -92.8% | −$18.7M | −$18.9M | -2737.6% | -23.62 | −$12M | $847K | −$12.9M | — | — |
| FY2021 · to Dec 31 | $160K | 65.6% | −$6.5M | −$7M | -4405.0% | -7.81 | −$4.3M | $102K | −$4.4M | — | — |
Every number comes from Tenon Medical, Inc.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.